Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15937949rdf:typepubmed:Citationlld:pubmed
pubmed-article:15937949lifeskim:mentionsumls-concept:C0031437lld:lifeskim
pubmed-article:15937949lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:15937949lifeskim:mentionsumls-concept:C1442161lld:lifeskim
pubmed-article:15937949pubmed:issue1lld:pubmed
pubmed-article:15937949pubmed:dateCreated2005-6-29lld:pubmed
pubmed-article:15937949pubmed:abstractTextTelomeres are gene rich regions with a high recombination rate. Cryptic subtelomeric rearrangements are estimated to account for 5% of mental retardation/malformation syndromes. Here we present the first patient with a deletion of 19p13.3, identified by subtelomeric FISH analysis. His features included a distinctive facial appearance, cleft palate, hearing impairment, congenital heart malformation, keloid scarring, immune dysregulation, and mild learning difficulties. Subtelomeric FISH analysis identified a deletion of 19p13.3-pter. The deletion size was determined to be 1.2 Mb by FISH analysis. It extended from within the chromosomal region covered by BAC RP11-50C6 to 19pter. The deleted area encompassed approximately 60 genes. Fifteen possible candidate genes were considered with respect to the phenotype, including follistatin-related precursor 3 (FSTL3) and serine-threonine kinase 11 (STK-11).lld:pubmed
pubmed-article:15937949pubmed:languageenglld:pubmed
pubmed-article:15937949pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15937949pubmed:citationSubsetIMlld:pubmed
pubmed-article:15937949pubmed:statusMEDLINElld:pubmed
pubmed-article:15937949pubmed:monthJullld:pubmed
pubmed-article:15937949pubmed:issn1552-4825lld:pubmed
pubmed-article:15937949pubmed:authorpubmed-author:JohnsonDDlld:pubmed
pubmed-article:15937949pubmed:authorpubmed-author:GuptaSSlld:pubmed
pubmed-article:15937949pubmed:authorpubmed-author:WilliamsPPlld:pubmed
pubmed-article:15937949pubmed:authorpubmed-author:ThompsonPPlld:pubmed
pubmed-article:15937949pubmed:authorpubmed-author:WarrenSSlld:pubmed
pubmed-article:15937949pubmed:authorpubmed-author:LedbetterD...lld:pubmed
pubmed-article:15937949pubmed:authorpubmed-author:ChudLLlld:pubmed
pubmed-article:15937949pubmed:authorpubmed-author:PilzD TDTlld:pubmed
pubmed-article:15937949pubmed:authorpubmed-author:RowbottomAAlld:pubmed
pubmed-article:15937949pubmed:authorpubmed-author:EnochSSlld:pubmed
pubmed-article:15937949pubmed:authorpubmed-author:ArcherH LHLlld:pubmed
pubmed-article:15937949pubmed:authorpubmed-author:Lese-MartinCClld:pubmed
pubmed-article:15937949pubmed:copyrightInfoCopyright (c) 2005 Wiley-Liss, Inc.lld:pubmed
pubmed-article:15937949pubmed:issnTypePrintlld:pubmed
pubmed-article:15937949pubmed:day1lld:pubmed
pubmed-article:15937949pubmed:volume136lld:pubmed
pubmed-article:15937949pubmed:ownerNLMlld:pubmed
pubmed-article:15937949pubmed:authorsCompleteYlld:pubmed
pubmed-article:15937949pubmed:pagination38-44lld:pubmed
pubmed-article:15937949pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:meshHeadingpubmed-meshheading:15937949...lld:pubmed
pubmed-article:15937949pubmed:year2005lld:pubmed
pubmed-article:15937949pubmed:articleTitleDistinct phenotype associated with a cryptic subtelomeric deletion of 19p13.3-pter.lld:pubmed
pubmed-article:15937949pubmed:affiliationInstitute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom. archerhl@cardiff.ac.uklld:pubmed
pubmed-article:15937949pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15937949pubmed:publicationTypeReviewlld:pubmed
pubmed-article:15937949pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15937949lld:pubmed